Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Add Legal & General Group (LGEN) by Andrew Mackie in The Motley Fool
- Avoid Marks Electrical Group (MRK) by Steve Moore in ShareProphets
- Avoid THG (THG) by Steve Moore in ShareProphets
- Buy Water Intelligence (WATR) by Hot Stock Rockets in ShareProphets
- Avoid Headlam Group (HEAD) by Steve Moore in ShareProphets
- Avoid Pinewood Technologies Group (PINE) by Steve Moore in ShareProphets
- Buy Abrdn (ABDN) by Tom Winnifrith in ShareProphets
- Buy Abrdn (ABDN) by Steve Moore in ShareProphets
- Buy Capital Limited (DI) (CAPD) by Hot Stock Rockets in ShareProphets
- Avoid Aptamer Group (APTA) by Steve Moore in ShareProphets
- Hold S4 Capital (SFOR) by Deutsche Bank
- Buy Ecora Resources (ECOR) by Berenberg
- Hold Kenmare Resources (CDI) (KMR) by Berenberg
- Buy Luceco (LUCE) by Deutsche Bank
- Outperform Ecora Resources (ECOR) by RBC Capital
- Buy BAE Systems (BA.) by Bank of America
- Hold Reckitt Benckiser Group (RKT) by Deutsche Bank
- Neutral Bellway (BWY) by Goldman Sachs
- Buy BP (BP.) by Goldman Sachs
- Buy HSBC Holdings (HSBA) by Goldman Sachs
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,441 open tips for GSK (GSK)
| Latest Bid : 2,043.00p | Latest Ask : 2,045.00p |
| High Today : 2,060.29p | Low Today : 2,022.68p |
| This Years High : 2,208.00p | This Years Low : 1,264.00p |
| Volume : 4,099,489 | MKT Cap : £84931.05M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2025-02-06 07:17:00 06/02/2025 | -3.67% |
| Neutral | UBS | Premium Only | 2025-02-06 04:45:00 06/02/2025 | – |
| Hold | Harvey Jones | Premium Only | 2025-01-26 08:30:00 26/01/2025 | 50.11% |
| Buy | Simon Watkins | Premium Only | 2025-01-22 08:30:00 22/01/2025 | 50.77% |
| Hold | Jefferies | Premium Only | 2025-01-20 04:37:00 20/01/2025 | 7.41% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.52% | 16/03/2026 |
| Latest Bid : 2,043.00p | Latest Ask : 2,045.00p |
| High Today : 2,060.29p | Low Today : 2,022.68p |
| This Years High : 2,208.00p | This Years Low : 1,264.00p |
| Volume : 4,099,489 | MKT Cap : £84931.05M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2025-02-06 07:17:00 06/02/2025 | -3.67% |
| Neutral | UBS | Premium Only | 2025-02-06 04:45:00 06/02/2025 | – |
| Hold | Harvey Jones | Premium Only | 2025-01-26 08:30:00 26/01/2025 | 50.11% |
| Buy | Simon Watkins | Premium Only | 2025-01-22 08:30:00 22/01/2025 | 50.77% |
| Hold | Jefferies | Premium Only | 2025-01-20 04:37:00 20/01/2025 | 7.41% |